Published in Diabetologia on October 21, 2004
Resistin, an adipocytokine, offers protection against acute myocardial infarction. J Mol Cell Cardiol (2007) 0.91
Ang II-stimulated migration of vascular smooth muscle cells is dependent on LR11 in mice. J Clin Invest (2008) 0.89
Adipocytes as a vehicle for ex vivo gene therapy: Novel replacement therapy for diabetes and other metabolic diseases. J Diabetes Investig (2011) 0.79
Effects of over-expressing resistin on glucose and lipid metabolism in mice. J Zhejiang Univ Sci B (2008) 0.79
Resistin as a putative modulator of insulin action in the daily feeding/fasting rhythm. Pflugers Arch (2006) 0.78
The optimization principle in phylogenetic analysis tends to give incorrect topologies when the number of nucleotides or amino acids used is small. Proc Natl Acad Sci U S A (1998) 15.43
Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun (1999) 14.25
CRM1 is responsible for intracellular transport mediated by the nuclear export signal. Nature (1997) 10.49
Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler Thromb Vasc Biol (2000) 9.85
Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin. Circulation (2000) 6.96
Surface density of calcium ions and calcium spikes in the barnacle muscle fiber membrane. J Gen Physiol (1967) 6.59
The anomalous rectification and cation selectivity of the membrane of a starfish egg cell. J Membr Biol (1974) 6.43
E-CELL: software environment for whole-cell simulation. Bioinformatics (1999) 6.29
Prevention of second primary tumors by an acyclic retinoid, polyprenoic acid, in patients with hepatocellular carcinoma. Hepatoma Prevention Study Group. N Engl J Med (1996) 6.01
The t(4;11) chromosome translocation of human acute leukemias fuses the ALL-1 gene, related to Drosophila trithorax, to the AF-4 gene. Cell (1992) 5.39
Adiponectin, an adipocyte-derived plasma protein, inhibits endothelial NF-kappaB signaling through a cAMP-dependent pathway. Circulation (2000) 5.36
PPARgamma ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein. Diabetes (2001) 5.18
Epilepsy and exacerbation of brain injury in mice lacking the glutamate transporter GLT-1. Science (1997) 5.13
Bidirectional SV40 transcription mediated by tandem Sp1 binding interactions. Science (1985) 5.00
Identification of a fibroblast-derived epithelial morphogen as hepatocyte growth factor. Cell (1991) 4.98
A cyclic nucleotide-gated conductance in olfactory receptor cilia. Nature (1987) 4.81
Requirement of stereospecific alignments for initiation from the simian virus 40 early promoter. Nature (1986) 4.77
STAT3 activation is sufficient to maintain an undifferentiated state of mouse embryonic stem cells. EMBO J (1999) 4.55
Regulation of DNA-replication origins during cell-cycle progression. Nature (1998) 4.52
Clinical application of transvenous mitral commissurotomy by a new balloon catheter. J Thorac Cardiovasc Surg (1984) 4.45
Abdominal fat: standardized technique for measurement at CT. Radiology (1999) 4.25
Interleukin (IL)-6 directs the differentiation of IL-4-producing CD4+ T cells. J Exp Med (1997) 4.06
Partial purification and characterization of hepatocyte growth factor from serum of hepatectomized rats. Biochem Biophys Res Commun (1984) 3.70
Immunochemical structure of hepatitis B e antigen in the serum. J Immunol (1983) 3.50
Phosphorylation of myosin-binding subunit (MBS) of myosin phosphatase by Rho-kinase in vivo. J Cell Biol (1999) 3.43
Post-tetanic hyperpolarization and electrogenic Na pump in stretch receptor neurone of crayfish. J Physiol (1966) 3.42
Role of IQGAP1, a target of the small GTPases Cdc42 and Rac1, in regulation of E-cadherin- mediated cell-cell adhesion. Science (1998) 3.39
Variant of penicillinase mediated by an R factor in Escherichia coli. J Bacteriol (1970) 3.33
Purification and characterization of a novel type of fimbriae from the oral anaerobe Bacteroides gingivalis. J Bacteriol (1984) 3.27
Stroke protection by 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase inhibitors mediated by endothelial nitric oxide synthase. Proc Natl Acad Sci U S A (1998) 3.23
Molecular cloning and sequence analysis of cDNA for human hepatocyte growth factor. Biochem Biophys Res Commun (1989) 3.21
Leukaemia disease genes: large-scale cloning and pathway predictions. Nat Genet (1999) 3.19
Expression of transforming growth factor beta is elevated in human and experimental diabetic nephropathy. Proc Natl Acad Sci U S A (1993) 3.16
The human tumor cell-derived collagenase stimulatory factor (renamed EMMPRIN) is a member of the immunoglobulin superfamily. Cancer Res (1995) 3.04
Evolutionary motif and its biological and structural significance. J Mol Evol (1997) 3.03
Enhanced expression of PAI-1 in visceral fat: possible contributor to vascular disease in obesity. Nat Med (1996) 3.02
Molecular cloning of a porcine gene syk that encodes a 72-kDa protein-tyrosine kinase showing high susceptibility to proteolysis. J Biol Chem (1991) 2.89
Yeast KEX2 genes encodes an endopeptidase homologous to subtilisin-like serine proteases. Biochem Biophys Res Commun (1988) 2.89
Mis6, a fission yeast inner centromere protein, acts during G1/S and forms specialized chromatin required for equal segregation. Cell (1997) 2.88
Specific protein binding to the simian virus 40 enhancer in vitro. Mol Cell Biol (1986) 2.82
Bni1p and Bnr1p: downstream targets of the Rho family small G-proteins which interact with profilin and regulate actin cytoskeleton in Saccharomyces cerevisiae. EMBO J (1997) 2.80
Atomic Control of the SrTiO3 Crystal Surface. Science (1994) 2.72
Primary structure of elongation factor Tu from Escherichia coli. Proc Natl Acad Sci U S A (1980) 2.72
Reduction of serum uric acid by hormone replacement therapy in postmenopausal women with hyperuricaemia. Lancet (1999) 2.71
Isolation of Rickettsia tsutsugamushi antigenically different from Kato, Karp, and Gilliam strains from patients. Microbiol Immunol (1984) 2.70
The reaction of phenylglyoxal with arginine residues in proteins. J Biol Chem (1968) 2.67
Inhibition of Wnt signaling by ICAT, a novel beta-catenin-interacting protein. Genes Dev (2000) 2.65
Calcium and potassium currents of the membrane of a barnacle muscle fibre in relation to the calcium spike. J Physiol (1969) 2.63
Trithorax and dCBP acting in a complex to maintain expression of a homeotic gene. Science (2001) 2.61
An adipocyte-derived plasma protein, adiponectin, adheres to injured vascular walls. Horm Metab Res (2000) 2.59
Seroepidemiology of human herpesvirus 6 infection in normal children and adults. J Clin Microbiol (1989) 2.58
Meis proteins are major in vivo DNA binding partners for wild-type but not chimeric Pbx proteins. Mol Cell Biol (1997) 2.57
Demonstration of hepatitis B e antigen in the core of Dane particles. J Immunol (1979) 2.56
Tumorigenicity of the met proto-oncogene and the gene for hepatocyte growth factor. Mol Cell Biol (1992) 2.53
The Arabidopsis HKT1 gene homolog mediates inward Na(+) currents in xenopus laevis oocytes and Na(+) uptake in Saccharomyces cerevisiae. Plant Physiol (2000) 2.53
The C-terminal SET domains of ALL-1 and TRITHORAX interact with the INI1 and SNR1 proteins, components of the SWI/SNF complex. Proc Natl Acad Sci U S A (1998) 2.52
Hepatocyte growth factor gene therapy of liver cirrhosis in rats. Nat Med (1999) 2.51
Onset of re-epithelialization after skin injury correlates with a reorganization of keratin filaments in wound edge keratinocytes: defining a potential role for keratin 16. J Cell Biol (1996) 2.49
A hepatitis B surface antigen polypeptide (P31) with the receptor for polymerized human as well as chimpanzee albumins. Gastroenterology (1983) 2.49
A tumor promoter induces rapid and coordinated reorganization of actin and vinculin in cultured cells. J Cell Biol (1984) 2.46
Molecular mechanism of metabolic syndrome X: contribution of adipocytokines adipocyte-derived bioactive substances. Ann N Y Acad Sci (1999) 2.44
Upregulation of Meis1 and HoxA9 in acute lymphocytic leukemias with the t(4 : 11) abnormality. Oncogene (2001) 2.42
Ampulla cardiomyopathy ('Takotusbo' cardiomyopathy)--reversible left ventricular dysfunction: with ST segment elevation. Jpn Circ J (2000) 2.39
Complexity of terminal airspace geometry assessed by lung computed tomography in normal subjects and patients with chronic obstructive pulmonary disease. Proc Natl Acad Sci U S A (1999) 2.38
Purification and characterization of a growth factor from rat platelets for mature parenchymal hepatocytes in primary cultures. Proc Natl Acad Sci U S A (1986) 2.37
Non-A, non-B hepatitis specific antibodies directed at host-derived epitope: implication for an autoimmune process. Lancet (1990) 2.35
Preparation of bioactive Ti and its alloys via simple chemical surface treatment. J Biomed Mater Res (1996) 2.34
Emerging multipotent aspects of hepatocyte growth factor. J Biochem (1996) 2.34
Membrane currents of the tunicate egg under the voltage-clamp condition. J Physiol (1976) 2.32
Linkage of decreased bone mass with impaired osteoblastogenesis in a murine model of accelerated senescence. J Clin Invest (1996) 2.26
Islets-activating protein (IAP) in Bordetella pertussis that potentiates insulin secretory responses of rats. Purification and characterization. J Biochem (1978) 2.26
Longitudinal study of cerebrospinal fluid levels of tau, A beta1-40, and A beta1-42(43) in Alzheimer's disease: a study in Japan. Ann Neurol (1998) 2.25
Two components of the calcium current in the egg cell membrane of the tunicate. J Physiol (1976) 2.22
Purification and partial characterization of hepatocyte growth factor from plasma of a patient with fulminant hepatic failure. J Clin Invest (1988) 2.22
Analysis of polypeptide composition and antigenic components of Rickettsia tsutsugamushi by polyacrylamide gel electrophoresis and immunoblotting. Infect Immun (1985) 2.20
Mutations in the cardiac troponin I gene associated with hypertrophic cardiomyopathy. Nat Genet (1997) 2.20
Disruption of the fibroblast growth factor-2 gene results in decreased bone mass and bone formation. J Clin Invest (2000) 2.18
Polymorphism in RANTES chemokine promoter affects HIV-1 disease progression. Proc Natl Acad Sci U S A (1999) 2.17
Deduced primary structure of rat hepatocyte growth factor and expression of the mRNA in rat tissues. Proc Natl Acad Sci U S A (1990) 2.15
Incidence and factors associated with intrahepatic recurrence following resection of hepatocellular carcinoma. Gastroenterology (1993) 2.15
Functional brain networks in DYT1 dystonia. Ann Neurol (1998) 2.14
Abscopal regression of hepatocellular carcinoma after radiotherapy for bone metastasis. Gut (1998) 2.11
Faithful anaphase is ensured by Mis4, a sister chromatid cohesion molecule required in S phase and not destroyed in G1 phase. Genes Dev (1998) 2.10
Patterns of regional brain activation associated with different forms of motor learning. Brain Res (2000) 2.10
Slow and fast groups of pyramidal tract cells and their respective membrane properties. J Neurophysiol (1965) 2.09
Induction of hepatocyte growth factor in fibroblasts by tumor-derived factors affects invasive growth of tumor cells: in vitro analysis of tumor-stromal interactions. Cancer Res (1997) 2.06
Liver resection for hepatocellular carcinoma. Results of 229 consecutive patients during 11 years. Ann Surg (1993) 2.06
Identification of alpha-fodrin as a candidate autoantigen in primary Sjögren's syndrome. Science (1997) 2.06
p140Sra-1 (specifically Rac1-associated protein) is a novel specific target for Rac1 small GTPase. J Biol Chem (1998) 2.05
Effects of internal free calcium upon the sodium and calcium channels in the tunicate egg analysed by the internal perfusion technique. J Physiol (1978) 2.05
Structure and function of chicken gizzard myosin. J Biochem (1978) 2.05
Serum pepsinogens as a screening test of extensive chronic gastritis. Gastroenterol Jpn (1987) 2.03
Calcium and sodium contributions to regenerative responses in the embryonic excitable cell membrane. Science (1972) 2.03
Hepatocyte growth factor prevents endotoxin-induced lethal hepatic failure in mice. Hepatology (1999) 2.03
Prevention of type I diabetes in nonobese diabetic mice by allogenic bone marrow transplantation. Proc Natl Acad Sci U S A (1985) 2.03
Biological properties of islets-activating protein (IAP) purified from the culture medium of Bordetella pertussis. J Biochem (1978) 2.02